This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Upsa. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Nicole Bru: Innovator in Pharmaceutical Composition
Introduction
Nicole Bru is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable powder compositions for medical use. Her innovative work has the potential to improve treatment options for patients suffering from migraines.
Latest Patents
Nicole Bru holds a patent for a pharmaceutical composition designed for the preparation of a stable powder. This novel composition includes an association of acetylsalicylic acid and metoclopramide as the active ingredients. The acetylsalicylic acid is formulated as a water-soluble salt or complex, which is combined with metoclopramide or a pharmaceutically acceptable salt thereof. Additionally, at least one pharmaceutically acceptable hydrophilic polymer is included to stabilize the metoclopramide. This composition exhibits remarkable stability in powder form and is intended for use in sachets for migraine treatment.
Career Highlights
Nicole Bru is associated with Laboratoires Upsa, where she has been instrumental in advancing pharmaceutical innovations. Her work has not only contributed to the company's portfolio but has also enhanced the therapeutic options available for migraine sufferers.
Collaborations
Nicole collaborates with esteemed colleagues such as Jehan-Yves P Drouin and Jean-Francois S Cordoliani. Their combined expertise fosters a productive environment for innovation and development in the pharmaceutical sector.
Conclusion
Nicole Bru's contributions to pharmaceutical compositions exemplify the impact of innovative thinking in medicine. Her patent for a stable powder composition represents a significant advancement in migraine treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile